Qube Research & Technologies (QRT)
WGS icon

Qube Research & Technologies (QRT)’s GeneDx Holdings WGS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8M Buy
184,514
+109,106
+145% +$9.95M 0.01% 1176
2025
Q4 		$9.81M Buy
75,408
+57,809
+328% +$7.93M 0.01% 1359
2025
Q3 		$1.9M Buy
+17,599
New +$1.92M ﹤0.01% 2259
2025
Q2 		– Sell
-89,775
Closed -$7.95M – 4029
2025
Q1 		$7.95M Buy
89,775
+75,341
+522% +$6.54M 0.01% 1273
2024
Q4 		$1.11M Sell
14,434
-1,075
-7% -$75.1K ﹤0.01% 2126
2024
Q3 		$658K Buy
15,509
+3,721
+32% +$126K ﹤0.01% 2181
2024
Q2 		$308K Buy
+11,788
New +$223K ﹤0.01% 2297
2023
Q4 		– Sell
-1,939
Closed -$7.06K – 4791
2023
Q3 		$7.06K Buy
+1,939
New +$10.6K ﹤0.01% 3388
2022
Q2 		– Sell
-8,004
Closed -$811K – 3196
2022
Q1 		$811K Buy
8,004
+2,782
+53% +$309K 0.01% 1281
2021
Q4 		$769K Buy
+5,222
New +$1.17M 0.01% 1339

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Qube Research & Technologies (QRT)'s WGS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its GeneDx Holdings (WGS) stake by 145% in Q1 2026, buying an estimated $9.95M and bringing the position to 184,514 shares worth $11.8M. The position accounts for 0.01% of the portfolio, ranked #1176.

Qube Research & Technologies (QRT) first reported a position in WGS in Q4 2021 and has held it in 10 quarters since. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Qube Research & Technologies (QRT) held 184,514 shares of GeneDx Holdings worth $11.8M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 109,106 GeneDx Holdings shares in Q1 2026, an estimated $9.95M.
  • GeneDx Holdings made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1176 holding.
  • Qube Research & Technologies (QRT) first reported a position in GeneDx Holdings in Q4 2021 and has held it in 10 quarters since.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.